Stock REC RECORDATI
Add to a list
To use this feature you must be a member
Log inSign up

Recordati Stock

Equities

REC

IT0003828271

Pharmaceuticals

Market Closed - Borsa Italiana
Other stock markets
 11:45:00 2025-01-24 am EST 		5-day change 1st Jan Change
56.00 EUR +0.36% Intraday chart for Recordati +2.00% +10.67%
Jan. 17 Recordati and its top investor say no plans for deal with Angelini RE
Jan. 17 Recordati-Angelini, on the plan interest of sovereign wealth funds AN

Valuation: Recordati

Capitalization 11.45B 12.04B 10.89B 9.64B 17.25B 1,038B 19.04B 131B 48.24B 430B 45.11B 44.22B 1,874B P/E ratio 2024 *
26.4x
P/E ratio 2025 * 22.3x
Enterprise value 13.47B 14.16B 12.81B 11.34B 20.3B 1,221B 22.4B 155B 56.75B 505B 53.07B 52.02B 2,205B EV / Sales 2024 *
5.8x
EV / Sales 2025 * 5.05x
Free-Float
-
Yield 2024 *
2.45%
Yield 2025 * 2.75%
More valuation ratios * Estimated data

Chart: Recordati

Dynamic Chart

Latest news: Recordati

Recordati and its top investor say no plans for deal with Angelini Jan. 17 RE
Recordati-Angelini, on the plan interest of sovereign wealth funds Jan. 17 AN
Campari, Enel, FinecoBank, Iveco and UniCredit "best pick 2025" for Equita Jan. 14 RE
Indices expected to fall; euro still weak Jan. 03 AN
Europeans in the green; at the top Saipem, on the bottom BPER Jan. 02 AN
Milan stock market positive, good cars with Europe, brisk Tim Dec. 13 RE
Mib veers into red; up Moncler, down Leonardo Dec. 09 AN
Mib lone in green; focus on French vote Dec. 04 AN
Europeans in green, Korea tensions push Brent Dec. 03 AN
Italian stock market maglia rosa; Mib at 33,900 Dec. 03 AN
Stock markets in the green; Amplifon leads the rises on the Mib. Dec. 03 AN
Futures up slightly; focus on French crisis Dec. 03 AN
Business Square in the green; up Nexi, down Stellantis Dec. 02 AN
More news

Last Transcript: Recordati

Logo Recordati
Recordati Industria Chimica e Farmaceutica S.p.A., Nine Months 2024 Earnings Call, Nov 08, 2024
Nov. 08
More transcripts

Analysts' recommendations: Recordati

Analyst recommendations: Accenture, Comcast, DoorDash, Intel, Roku... 21-06-25Our Logo
More recommendations

Press Releases: Recordati

Recordati : January 15, 2025 - J.P. Morgan Healthcare Conference Presentation Jan. 15 PU
RECORDATI : COMPLETES THE ACQUISITION OF THE GLOBAL RIGHTS TO ENJAYMO® Nov. 29 PU
RECORDATI: UPDATE ON THE EXECUTION OF THE SHARE BUY-BACK PROGRAM. CONCLUSION OF THE PROGRAM INITIATED ON 10th MAY 2024. Nov. 11 PU
RECORDATI: SHARE BUY-BACK PROGRAM TO SERVICE THE STOCK OPTION/PERFORMANCE SHARES PLANS Nov. 11 PU
Recordati : First nine months 2024 Nov. 11 PU
More press releases

News in other languages: Recordati

Recordati prosegue buyback con acquisto di oltre 62.000 azioni Jan. 21
Borsa : Europa apre bene in scia a pil Cina, Milano (+0,6%) sopra 36mila al top da 2008 Jan. 17
Recordati-Angelini, sul piano interesse dei fondi sovrani Jan. 17
Recordati prosegue programma di buyback e acquista oltre 30.000 azioni Jan. 14
Campari, Enel, FinecoBank, Iveco e UniCredit "best pick 2025" per Equita Jan. 14
More news

Quotes and Performance

1 day+0.36%
1 week+2.00%
Current month+10.67%
1 month+10.89%
3 months+4.19%
6 months+7.18%
Current year+10.67%
More quotes

Course Extremes

1 week
54.40
Extreme 54.4
56.30
1 month
49.60
Extreme 49.6
56.30
Current year
50.65
Extreme 50.65
56.30
1 year
47.28
Extreme 47.28
56.30
3 years
34.52
Extreme 34.52
56.30
5 years
28.26
Extreme 28.26
57.90
10 years
13.51
Extreme 13.51
57.90
More quotes

Managers and Directors: Recordati

Director TitleAgeSince
Robert Koremans CEO
 Chief Executive Officer 62 2021-11-30
Luigi la Corte DFI
 Director of Finance/CFO 55 2019-10-31
Raffaele Sabia CTO
 Chief Tech/Sci/R&D Officer - 2017-06-30
Manager TitleAgeSince
Andrea Recordati CHM
 Chairman 53 2021-11-30
Michaela Castelli BRD
 Director/Board Member 54 2014-04-16
Giampiero Mazza CHM
 Chairman 55 2018-06-11
More insiders

ETFs: Recordati

Name Weight AuM 1st Jan change Investor Rating
FRANKLIN FTSE ITALY ETF - USD ETF Franklin FTSE Italy ETF - USD
1.52% 0 M€ +12.55%
More ETFs: Recordati

Other Pharmaceuticals

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
RECORDATI Stock Recordati
+0.36%+2.00%+12.04%+12.11%12.04B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+2.45%+8.22%+25.14%+227.99%707B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+7.13%+8.13%-14.02%+99.10%389B
JOHNSON & JOHNSON Stock Johnson & Johnson
+0.12%-0.14%-7.98%-12.41%353B
ABBVIE INC. Stock AbbVie Inc.
-0.22%-0.73%+3.13%+27.96%301B
ROCHE HOLDING AG Stock Roche Holding AG
+0.18%+3.58%+13.60%-20.60%244B
MERCK & CO., INC. Stock Merck & Co., Inc.
-1.12%-2.42%-20.46%+20.25%242B
ASTRAZENECA PLC Stock AstraZeneca PLC
+0.04%+1.02%+5.76%+30.63%214B
NOVARTIS AG Stock Novartis AG
0.00%+1.05%-2.68%+16.89%199B
AMGEN INC. Stock Amgen Inc.
-0.89%+1.22%-11.23%+22.39%148B
Average +0.80%+2.32%+0.33%+42.43% 281.05B
Weighted average by Cap. +1.47%+3.45%+2.84%+77.25%
See all sector performances

Financials

2024 *2025 *
Net sales 2.32B 2.44B 2.21B 1.95B 3.5B 210B 3.86B 26.63B 9.78B 87.09B 9.15B 8.96B 380B 2.61B 2.74B 2.48B 2.19B 3.93B 236B 4.33B 29.88B 10.98B 97.73B 10.26B 10.06B 426B
Net income 465M 489M 442M 391M 701M 42.14B 773M 5.33B 1.96B 17.44B 1.83B 1.8B 76.11B 538M 566M 512M 453M 811M 48.75B 895M 6.17B 2.27B 20.18B 2.12B 2.08B 88.06B
Net Debt 2.02B 2.12B 1.92B 1.7B 3.04B 183B 3.36B 23.17B 8.51B 75.77B 7.96B 7.8B 331B 1.7B 1.79B 1.62B 1.43B 2.56B 154B 2.83B 19.49B 7.16B 63.74B 6.69B 6.56B 278B
More financial data * Estimated data

Company Profile

Logo Recordati
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical and OTC products (65.7%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.; - medicines for rare diseases (34.3%). Net sales are distributed geographically as follows: Italy (15.2%), Europe (56.4%), America (19%), Asia and Oceania (6.7%) and Africa (2.7%).
Employees
4,455
Sector
Pharmaceuticals
Calendar
2025-02-19 - Q4 2024 Earnings Release (Projected)
More about the company

Quotes

Date Price Change Volume
25-01-24 56.00 € +0.36% 533,536
25-01-23 55.80 € +0.09% 281,765
25-01-22 55.75 € +1.09% 316,309
25-01-21 55.15 € +1.01% 205,331
25-01-20 54.60 € -0.55% 223,711

Real-time Borsa Italiana, January 24, 2025 at 11:45 am EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart RECORDATI More financial data

Ratings

Trading Rating
Investor Rating
ESG MSCI
A
surperformance-ratings-light-chart RECORDATIMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
56.00EUR
Average target price
55.74EUR
Spread / Average Target
-0.46%
Consensus
Profit revisions
estimates-change-chart RECORDATI Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart RECORDATI Company calendar
  1. Stock Market
  2. Equities
  3. REC Stock